alexa
Reach Us +1(802)342-4982
Molecular Classification of Patients with Cutaneous Melanoma: A Reality | OMICS International | Abstract
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Molecular Classification of Patients with Cutaneous Melanoma: A Reality

Giuseppe Palmieri1, Carla Rozzo1, Antonio Cossu2 and Paolo A Ascierto3*

1Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Sassari, Italy

2Anatomia Patologica, Azienda Ospedaliero Universitaria, Sassari, Italy

3Istituto Nazionale Tumori “Fondazione Pascale”, Napoli, Italy

*Corresponding Author:
Paolo A Ascierto
Istituto Nazionale Tumori “Fondazione Pascale”, Napoli, Italy
Tel: +39-081-5903841
Fax: +39-081-5903841
E-mail: [email protected]

Received date: September 17, 2012; Accepted date: September 18, 2012; Published date: September 20, 2012

Citation: Palmieri G, Rozzo C, Cossu A, Ascierto PA (2012) Molecular Classification of Patients with Cutaneous Melanoma: A Reality. J Mol Biomark Diagn 3:e110. doi:10.4172/2155-9929.1000e110

Copyright: © 2012 Palmieri G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Melanoma is the most aggressive skin cancer and, despite great progresses recently assessed into the biology research and the diagnosis approaches, its incidence and mortality have extremely risen in all developed countries during the last half century

Recommended Conferences

15th Global Biomarkers and Clinical Research Summit

Vienna, Austria

2nd International Conference on Biomarkers and Cancer Targets

Capetown, South Africa
Share This Page
Top